Cox-nnet: an artificial neural network Cox regression for prognosis prediction
暂无分享,去创建一个
[1] M. Gevrey,et al. Review and comparison of methods to study the contribution of variables in artificial neural network models , 2003 .
[2] Joshua Zhexue Huang,et al. Unbiased Feature Selection in Learning Random Forests for High-Dimensional Data , 2015, TheScientificWorldJournal.
[3] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[4] Harvey Risch,et al. Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer , 2016, Oncotarget.
[5] H. Tarhan,et al. p53 Mutations and Other Prognostic Factors of Renal Cell Carcinoma , 2001, Urologia Internationalis.
[6] Russell G. Death,et al. An accurate comparison of methods for quantifying variable importance in artificial neural networks using simulated data , 2004 .
[7] Tom C. Freeman,et al. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data , 2008, Molecular Cancer Therapeutics.
[8] A. Adjei,et al. Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy , 2008, Clinical Cancer Research.
[9] D Faraggi,et al. A neural network model for survival data. , 1995, Statistics in medicine.
[10] Hemant Ishwaran,et al. Random Survival Forests , 2008, Wiley StatsRef: Statistics Reference Online.
[11] R. Medeiros,et al. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population , 2013, Molecular Biology Reports.
[12] J. Koziol,et al. The Concordance Index C and the Mann–Whitney Parameter Pr(X>Y) with Randomly Censored Data , 2009, Biometrical journal. Biometrische Zeitschrift.
[13] Lana X. Garmire,et al. A Novel Model to Combine Clinical and Pathway-Based Transcriptomic Information for the Prognosis Prediction of Breast Cancer , 2014, PLoS Comput. Biol..
[14] Erwin G. Van Meir,et al. Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development , 2011, Journal of Molecular Medicine.
[15] Martin J. Wainwright,et al. Noisy matrix decomposition via convex relaxation: Optimal rates in high dimensions , 2011, ICML.
[16] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[17] Yusuke Nakamura,et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis , 1997, Oncogene.
[18] Keith T Flaherty,et al. Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] T. Fujioka,et al. Brain-specific angiogenesis inhibitor 1 is a putative factor for inhibition of neovascular formation in renal cell carcinoma. , 2011, The Journal of urology.
[20] L. V. van't Veer,et al. Cross‐validated Cox regression on microarray gene expression data , 2006, Statistics in medicine.